You have 9 free searches left this month | for more free features.

City

Cologne (1)

New York (1)

Condition

Hodgkin Lymphoma (1)

Lymphoma, T-Cell, Cutaneous (1)

Peripheral T Cell Lymphoma (1)

Relapsed or Refractory Hodgkin Lymphoma (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Affimed GmbH (1)

Ahmed Sawas (1)

University of Cologne (1)

Collaborator

Affimed GmbH (1)

Artiva Biotherapeutics, Inc. (1)

The Leukemia and Lymphoma Society (1)

Intervention

afm13 (3)

ab-101 (1)

cyclophosphamide (1)

fludarabine (1)

interleukin-2 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

afm13

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

Not yet recruiting

Relapsed or Refractory Hodgkin Lymphoma
Peripheral T Cell Lymphoma

AFM13
+4 more

(no location specified)

May 30, 2023

Hodgkin Lymphoma Trial in Cologne (AFM13)

Completed

Hodgkin Lymphoma

AFM13

Cologne, Germany

1st Department of Medicine, Cologne University Hospital

Nov 11, 2020

Lymphoma, T-Cell, Cutaneous Trial in New York (AFM13)

Completed

Lymphoma, T-Cell, Cutaneous

AFM13

New York, New York

Center for Lymphoid Malignancies

Jul 14, 2020